ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
121.28
+1.81 (1.52%)
At close: Feb 27, 2026, 4:00 PM EST
120.20
-1.08 (-0.89%)
After-hours: Feb 27, 2026, 7:57 PM EST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $9.44 billion as of February 27, 2026. Its market cap has increased by 2,041.40% in one year.
Market Cap
9.44B
Enterprise Value
8.83B
1-Year Change
2,041.40%
Ranking
Category
Stock Price
$121.28
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $9.44B, an increase of 4,084.87%. That is a compound annual growth rate of 41.84%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avidity Biosciences | 11.30B |
| ImmunityBio | 10.05B |
| Madrigal Pharmaceuticals | 9.91B |
| Praxis Precision Medicines | 9.38B |
| Bio-Techne | 9.23B |
| Vaxcyte | 8.89B |
| Arrowhead Pharmaceuticals | 8.86B |
| Axsome Therapeutics | 8.39B |